Assessing efficacy and safety of stereotactic body radiation therapy for oligometastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) wild type

BACKGROUND: Stereotactic body radiation therapy (SBRT) is an emerging therapy for oligometastatic cancer. The aim of this study was to investigate the efficacy and safety of high-dose radiotherapy for primary and oligometastatic lesions in epidermal growth factor receptor (EGFR) wild-type non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaolong, Li, Hongqi, Liu, Hefei, Liu, Zhifei, Xia, Tingyi, Zhang, Jianchun, Wang, Yingjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797444/
https://www.ncbi.nlm.nih.gov/pubmed/35116250
http://dx.doi.org/10.21037/tcr-20-2772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797444/
https://www.ncbi.nlm.nih.gov/pubmed/35116250
http://dx.doi.org/10.21037/tcr-20-2772

Ejemplares similares